Gentian Diagnostics AS Cash Flow Reinvestment Rate
Gentian Diagnostics AS cash flow reinvestment rate. Gentian Diagnostics AS (GENT) has a Cash Flow Reinvestment Rate of 0.25x as of December 2025, reinvesting Nkr10.76 Million (capex Nkr10.76 Million ) from operating cash flow of Nkr42.59 Million. See financial flexibility index of Gentian Diagnostics AS to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Gentian Diagnostics AS (2013–2025)
Cash flow reinvestment rate of Gentian Diagnostics AS from 2013 to 2025. Historical reinvestment intensity for Gentian Diagnostics AS across 4 annual periods. Explore Gentian Diagnostics AS cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Gentian Diagnostics AS Cash Flow Reinvestment Rate by Year (2013–2025)
Gentian Diagnostics AS cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Gentian Diagnostics AS. For the full cash flow conversion analysis, see how efficiently does Gentian Diagnostics AS generate cash.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | Nkr10.76 Million | Nkr42.59 Million | Nkr10.76 Million | ▼ -84.5% |
| 2024 | 1.63x | Nkr21.90 Million | Nkr13.46 Million | Nkr10.95 Million | ▲ +147.8% |
| 2023 | 0.66x | Nkr10.15 Million | Nkr15.46 Million | Nkr4.49 Million | ▼ -54.2% |
| 2013 | 1.44x | Nkr3.49 Million | Nkr2.43 Million | Nkr3.49 Million | — |